NO20070486L - 1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat - Google Patents

1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat

Info

Publication number
NO20070486L
NO20070486L NO20070486A NO20070486A NO20070486L NO 20070486 L NO20070486 L NO 20070486L NO 20070486 A NO20070486 A NO 20070486A NO 20070486 A NO20070486 A NO 20070486A NO 20070486 L NO20070486 L NO 20070486L
Authority
NO
Norway
Prior art keywords
phenylglycinyl
methylpiperidin
indole
piperazine
carbonyl
Prior art date
Application number
NO20070486A
Other languages
English (en)
Inventor
Julie Kay Bush
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20070486L publication Critical patent/NO20070486L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

l-(indol-6-karbonyl-D-fenylglysinyl)-4-(l-metylpiperidin -4-yl)-piperazin D-tartrat danner et stabilt krystallinsk salt og er en inhibitor av sirinproteasen, faktor Xa, anvendelig ved behandling av kardiovaskulære forstyrrelser.
NO20070486A 2004-06-30 2007-01-25 1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat NO20070486L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58359904P 2004-06-30 2004-06-30
PCT/US2005/020490 WO2006011955A1 (en) 2004-06-30 2005-06-13 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate

Publications (1)

Publication Number Publication Date
NO20070486L true NO20070486L (no) 2007-01-25

Family

ID=35276192

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070486A NO20070486L (no) 2004-06-30 2007-01-25 1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat

Country Status (19)

Country Link
US (1) US20070249623A1 (no)
EP (1) EP1763521A1 (no)
JP (1) JP2008505075A (no)
CN (1) CN1984903A (no)
AR (1) AR049659A1 (no)
AU (1) AU2005267579A1 (no)
BR (1) BRPI0512245A (no)
CA (1) CA2570634A1 (no)
EA (1) EA010307B1 (no)
EC (1) ECSP067105A (no)
IL (1) IL179903A0 (no)
MA (1) MA28842B1 (no)
MX (1) MXPA06015112A (no)
NO (1) NO20070486L (no)
PE (1) PE20060480A1 (no)
SV (1) SV2006002156A (no)
TW (1) TW200603806A (no)
WO (1) WO2006011955A1 (no)
ZA (1) ZA200610091B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
CN107365304A (zh) * 2017-08-01 2017-11-21 齐宜涛 一种治疗心血管疾病的化合物及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
GB9821058D0 (en) * 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
WO2000055131A1 (en) * 1999-03-15 2000-09-21 Novo Nordisk A/S New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
ATE303988T1 (de) * 1999-06-14 2005-09-15 Lilly Co Eli Inhibitoren von serin proteasen
US6448293B1 (en) * 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0019228D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
ME00466B (me) * 2001-05-14 2011-10-10 Pfizer Prod Inc Tartaratne soli 5,8,14-triazatetraciklo( 10.3.1.02,11.04,9)-heksadeka-2 (11),3,5,7,9-pentaena
TWI257389B (en) * 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound

Also Published As

Publication number Publication date
CA2570634A1 (en) 2006-02-02
IL179903A0 (en) 2007-05-15
EA010307B1 (ru) 2008-08-29
EP1763521A1 (en) 2007-03-21
AU2005267579A1 (en) 2006-02-02
JP2008505075A (ja) 2008-02-21
CN1984903A (zh) 2007-06-20
TW200603806A (en) 2006-02-01
MXPA06015112A (es) 2007-02-08
MA28842B1 (fr) 2007-09-03
US20070249623A1 (en) 2007-10-25
ECSP067105A (es) 2007-01-26
ZA200610091B (en) 2008-02-27
EA200700186A1 (ru) 2007-06-29
PE20060480A1 (es) 2006-07-13
WO2006011955A1 (en) 2006-02-02
SV2006002156A (es) 2006-02-15
BRPI0512245A (pt) 2008-02-19
AR049659A1 (es) 2006-08-23

Similar Documents

Publication Publication Date Title
NO20061562L (no) Anvendelse av 1- [4-(5-cyanindol-3yl)butyl ] -4-(2-karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptable salter
CY1119076T1 (el) Αλατα πιπεραζινης ως ανταγωνιστες των d3/d2
HRP20080137T3 (en) Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors
RS51013B (sr) Indolinon supstituisan na poziciji 6, njegovo dobijanje i njegova upotreba kao leka
ME01571B (me) Polimorfni oblici 3-(4-amin0-1-0ks0-1, 3-dihidro-izoindol-2-il)-piperidin-2, 6-diona
TW200732324A (en) Novel compounds that are ERK inhibitors
CR9783A (es) Inhibidores macrociclicos del virus de la hepatitis c
RS51560B (en) 1- [2- (2,4-DIMETHYLPHENYLSULPHANYL) PHENYL] PIPERAZINE AS A COMPONENT WITH COMBINED ACTIVITY RELATED TO THE RE-TAKING OF SEROTONIN AND 5-HT3 AND 5HT1A ACTIVITY, FOR TREATMENT OF PATIENTS OR SIMULAR DISEASES
HRP20050287A2 (en) Indole-3-carboxamides as glucokinase (gk) activators
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
TW200616952A (en) Novel crystal form of (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]-methanone, hydrochloride
NO20070486L (no) 1-(indol-6-karbonyl-D-fenylglycinyl)-4-(1-metylpiperidin-4-yl) piperazin D-tartrat
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
MY137876A (en) Pharmaceutical compound
CY1112878T1 (el) Νεο αλας βενζοϋλογονανιδινης
DE50304858D1 (de) N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetemid-und entsprechende piperidinderivate als faktor xa inhibitoren zur behandlung von thromboembolischen erkrankungen
ATE468855T1 (de) Kombination von stickstoff-senf analogen und imatinib für die behandlung von chronischer lymphatischer leukämie
AU2003216621A1 (en) Combination of glivec(sti571) with a cyclin-dependent kinase inhibitor, especially flavopiridol in the treatment of cancer
DE602004022540D1 (de) Verwendung von tyrosin-kinase-hemmern zur behandlung von diabetes
AU2003282566A8 (en) Piperazine and piperazinone inhibitors of factor xa
SI1492767T1 (sl) Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze
MX2007002913A (es) Proceso para preparar n-(arilmetil sustituido)-4-sustituido-4-(met il disustituido)piperidinas y productos intermedios.
DE60305460D1 (de) Verwendung von 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl benzamid zur behandlung von seminomen
SE0202673D0 (sv) Chemical compounds
DE50304950D1 (de) Ethan-1,2-diaminium-bis((2r)-2-brom-3-phenylpropanoat), verfahren zu dessen herstellung und dessen verwendung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application